Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung lipids and disease.

T Higenbottam1

  • 1Department of Respiratory Physiology, Papworth Hospital, UK.

Respiration; International Review of Thoracic Diseases
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Pulmonary surfactant protects lungs from toxins. Smoking sequesters surfactant, potentially causing lung injury and disease by altering its protective functions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing.

The World Allergy Organization journal·2019
Same author

Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy.

Allergy·2018
Same author

The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level.

The European respiratory journal·2008
Same author

Developments in inhaled immunosuppressive therapy for the prevention of pulmonary graft rejection.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Relationship between respiratory symptoms and medical treatment in exacerbations of COPD.

The European respiratory journal·2005
Same author

Understanding the mechanisms of drug-associated interstitial lung disease.

British journal of cancer·2004
Same journal

Real-world long-term efficacy of chemoimmunotherapy in advanced stage small cell lung cancer.

Respiration; international review of thoracic diseases·2026
Same journal

Residual AHI Measurement from PAP Devices Versus Home Polygraphy: A Method Comparison Study Using Real World Data.

Respiration; international review of thoracic diseases·2026
Same journal

Unveiling Sex Differences in Severe Acute COPD Exacerbations requiring ICU admission: Evidence from a French Cohort.

Respiration; international review of thoracic diseases·2026
Same journal

Intrapleural Fibrinolytics use in Children with Pleural Empyema: Safe and Effective.

Respiration; international review of thoracic diseases·2026
Same journal

Learning Curve for Transbronchial Lung Cryobiopsy in Interstitial Lung Disease Diagnosis: A Multicenter Experience.

Respiration; international review of thoracic diseases·2026
Same journal

Follow-Up Care After Adult Lung Transplantation: Summary of an Evidence-Based Clinical Practice Guideline for German-Speaking Countries.

Respiration; international review of thoracic diseases·2026
See all related articles

Area of Science:

  • Pulmonary physiology and toxicology
  • Cell biology of the lung

Background:

  • Pulmonary surfactant, a complex mix of phospholipids and proteins, is vital for lung function.
  • Beyond surface tension reduction, surfactant offers protection against inhaled toxins.
  • Disruption of the surfactant system can lead to lung injury and disease.

Purpose of the Study:

  • To explore the protective role of pulmonary surfactant.
  • To investigate the impact of cigarette smoke on the pulmonary surfactant system.
  • To understand the mechanisms linking surfactant dysfunction to lung disease in smokers.

Main Methods:

  • Review of existing physiological and histological studies on surfactant.
  • Analysis of the effects of tobacco smoke on surfactant properties in vitro.

Related Experiment Videos

  • Examination of surfactant sequestration in alveolar macrophages of smokers.

    • Main Results:

    • Pulmonary surfactant is synthesized by type II alveolar pneumocytes and forms a protective monolayer.
    • Cigarette smoke physically inactivates surfactant and alters lung compliance.
    • Smokers exhibit increased sequestration of surfactant into alveolar macrophages.

    Conclusions:

    • Smoking-induced surfactant dysfunction compromises lung protection.
    • This dysfunction may contribute to direct toxic injury and the development of chronic obstructive lung disease.